AnergiX AG284 myelin basic protein complexed to HLA-DR2 major histocompatibility complex molecule: Phase I

ANRG said that a placebo-controlled Phase I dose-escalation study in

Read the full 107 word article

How to gain access

Continue reading with a
two-week free trial.